Maria Marusinska

Dr. Maria Marusinska

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JDJakub Droś
Jakub Droś
RŚRafał Świstek
Rafał Świstek
PKPatryk Kasongo
Patryk Kasongo
JKJakub Konieczyński
Jakub Konieczyński
PBPiotr Bielański
Piotr Bielański
MTMichał Terlecki
Michał Terlecki
Background/Objectives: Previous research has demonstrated that the lactate/albumin ratio (L/A) may predict mortality among critically ill patients. Based on pathophysiological rationale, L/A may also correlate with volume status, however such an association has not been investigated extensively. This retrospective cohort study aimed to confirm the prognostic value of L/A and to assess the prognostic value of L/A and its relationship with hypovolemia severity in intensive care unit (ICU) patients. Methods: We analyzed data from consecutive adult patients admitted to the ICU. Admission L/A was evaluated in relation to 30-day mortality and indirect markers of volume status (mean arterial pressure on admission, median dose of norepinephrine and fluid intake within the first 24 h of ICU stay). Results: A total of 1421 patients were included. L/A ≥ 0.06 (estimated on the basis of ROC curve using the Youden index) was an independent predictor of 30-day mortality (HR = 1.423; 95%CI 1.183–1.712; p < 0.001). L/A moderately correlated with markers of absolute or relative hypovolemia, i.e., lower mean arterial pressure (r = −0.353, p < 0.001) on admission, higher norepinephrine dose (r = 0.506, p < 0.001) and greater fluid intake (r = 0.233, p < 0.001) within the first 24 h of ICU stay. Furthermore, L/A ≥ 0.06 on admission was an independent risk factor for the implementation of continuous renal replacement therapy (OR = 2.134; 95%CI 1.652–2.757; p = 0.001). Conclusions: L/A is not only a predictor of poor prognosis but also may be a valuable indirect marker of the extent of hypovolemia in critically ill patients. Further prospective studies are necessary to assess if this parameter should incline a decision for more aggressive fluid management in hypovolemic patients.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JWJęDrzej Wojciechowski
JęDrzej Wojciechowski
NONatalia Ostruszka
Natalia Ostruszka
JPJulia Pilecka
Julia Pilecka
SKSabina Kolawa
Sabina Kolawa
MMMaria Marusinska
Maria Marusinska
MPMichał Parzniewski
Michał Parzniewski
Noise is a widespread problem worldwide, only expected to grow due to the accelerating urbanization. Although not as well-documented as air pollution, there is substantial evidence of its detrimental effects on health. The effects of noise are usually divided into auditory and non-auditory ones, with cardiovascular disease, this review's main focus, being the most prevalent and well-researched among the latter. There is strong evidence for noise being a risk factor of cardiovascular diseases such as ischemic heart disease, myocardial infarction, and stroke. As the body of evidence grows, we are beginning to better understand not only the effects but also the mechanisms by which noise impacts one’s health. Cardiovascular diseases seem to be caused, among others, by excessive oxidative stress, endothelial dysfunction, and an increase in stress hormones and inflammatory mediators, which in turn promote atherosclerosis and elevate blood pressure. In this review, we will first show the extent to which noise has become a prevalent problem, then discuss possible mechanisms underlying the pathophysiology of noise-related cardiovascular disease, and present evidence for their association. Then, we will outline the areas of research with limited evidence or warrant further examination.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMichal Karpinski
Michal Karpinski
MMMaria Marusinska
Maria Marusinska
MPMichał Parzniewski
Michał Parzniewski
WCWiktoria Czyż
Wiktoria Czyż
SKSabina Kolawa
Sabina Kolawa
WMWojciech Markiewicz
Wojciech Markiewicz
Background: Tobacco smoking causes over eight million deaths annually and remains the leading preventable cause of disease worldwide (World Health Organization, 2023). Structural barriers limit access to counselling and pharmacotherapy, motivating the development of digital cessation tools across three modalities: smartphone applications, web-based programs, and AI conversational chatbots. Objective: This narrative review synthesises peer-reviewed evidence (2021–2026) on the efficacy, engagement, and equity of digital smoking-cessation interventions across these three modalities. Methods: PubMed and PMC were searched using MeSH and free-text terms for smoking cessation combined with smartphone applications, eHealth, SMS, chatbots, and artificial intelligence. Primary studies enrolled smokers aged ≥16 years reporting abstinence outcomes; secondary literature included systematic reviews, meta-analyses, and qualitative evaluations. Findings were synthesised thematically. Results: Smartphone apps combined with pharmacotherapy outperformed medication alone (OR 1.79, 95% CI 1.38–2.33; Guo et al., 2023), whereas standalone apps were non-significant. A 152-RCT network meta-analysis (Li et al., 2025) ranked personalized digital interventions above standard care (RR 1.86, 95% CI 1.54–2.24). AI chatbots showed early positive signals, including biochemically verified 6-month abstinence rates of 26.0% versus 18.8% under usual care (Olano-Espinosa et al., 2022). Engagement decay, self-reported outcomes, and limited population diversity were consistent weaknesses. Conclusions: Digital tools deliver clinically meaningful benefits when grounded in behavioural science frameworks and integrated with pharmacotherapy or human support. Future research needs to prioritise head-to-head comparisons, biochemically verified outcomes, equity-centred deployment, and moral governance for AI-delivered support.

29 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ABArnold Borowiec
Arnold Borowiec
NONatalia Ostruszka
Natalia Ostruszka
JPJulia Pilecka
Julia Pilecka
SKSabina Kolawa
Sabina Kolawa
JWJęDrzej Wojciechowski
JęDrzej Wojciechowski
MPMichał Parzniewski
Michał Parzniewski
Background: In many regions of the world where healthcare resources are limited, access to radiologists and the infrastructure necessary for diagnostic imaging is significantly restricted. The uneven distribution of resources leads to delayed diagnosis and, as a result, poorer treatment outcomes. In response to these challenges, teleradiology enables the remote transmission and interpretation of imaging studies, which can help reduce disparities in access to diagnostic imaging. Such solutions are particularly significant in rural and hard-to-reach areas. Despite the growing trend in the number and scope of telemedicine system implementations, the effectiveness of teleradiology in the context of systematically reducing diagnostic inequalities requires further analysis. Methods: A comprehensive PubMed and Cochrane Library search was performed using broad terms not specified to subtypes of medical imaging devices, including cohort studies, systematic reviews and meta-analyses from January 2020 to April 2026. Then, the articles were reviewed manually and selected based on the relevance for the review. Results: The available evidence suggests that the use of teleradiology and artificial intelligence models, in conjunction with mobile imaging systems, can effectively help address the shortage of radiologists, thereby increasing access to diagnostic imaging in healthcare and strengthening screening programs. It also facilitates multidisciplinary collaboration among specialists, leading to more accurate diagnoses and targeted treatment. Conclusions: In many low-resource regions, limited access to radiologists and diagnostic imaging infrastructure contributes to delayed diagnoses and poorer treatment outcomes. Teleradiology, by enabling remote image interpretation, may help reduce these disparities, particularly in rural and underserved areas. However, its effectiveness in systematically reducing diagnostic inequalities still requires further evaluation.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
NONatalia Ostruszka
Natalia Ostruszka
MMMaria Marusinska
Maria Marusinska
MKMichał Karpiński
Michał Karpiński
MPMichał Parzniewski
Michał Parzniewski
WCWiktoria Czyż
Wiktoria Czyż
JWJęDrzej Wojciechowski
JęDrzej Wojciechowski
Background: Wearable technologies - including consumer smartwatches, adhesive ECG patches and photoplethysmography-based sensors - have emerged as validated tools for continuous cardiovascular risk monitoring outside clinical settings. Objective: This review synthesizes peer-reviewed clinical evidence from 2020 to 2025 on the diagnostic performance and utility of wearable devices in detecting atrial fibrillation (AF), ischemic stroke risk, arterial hypertension and heart failure (HF). Methods: A structured PubMed/MEDLINE, Scopus and Cochrane Library search was performed using Boolean MeSH combinations for wearable devices, arrhythmia, stroke, hypertension and heart failure, restricted to English-language RCTs, cohort studies, systematic reviews and meta-analyses from January 2020 to April 2025. Results: Pooled meta-analysis demonstrates Apple Watch AF sensitivity of 96.4% and specificity of 97.2% (Iqbal et al., 2025). The iRhythm Zio XT Patch achieves 2.58-fold greater AF detection than standard monitoring and anticoagulation initiation 15.3 percentage points higher in monitored patients (mSToPS). Post-stroke AF detection was 2.73-fold higher with patch monitoring than Holter (EPCAS trial). Cuffless BP wearables achieve acceptable daytime accuracy (mean SBP error -0.99 mmHg vs. ABPM) but subthreshold nighttime performance (4.48 mmHg). The LINK-HF study predicted HF hospitalization with 87% sensitivity up to six days in advance. Conclusions: Wearable devices demonstrate clinically meaningful diagnostic utility across multiple cardiovascular domains. Nighttime BP inaccuracy, algorithm scope limitations and insufficient equity data remain key barriers to universal clinical integration.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
WCWiktoria Czyż
Wiktoria Czyż
ABArnold Borowiec
Arnold Borowiec
WMWojciech Markiewicz
Wojciech Markiewicz
MKMichał Karpiński
Michał Karpiński
MMMaria Marusinska
Maria Marusinska
MPMichał Parzniewski
Michał Parzniewski
Healthcare workers continue to experience high levels of occupational burnout, a crisis fueled by the COVID‑19 pandemic and the systemic cracks it exposed. To combat this, digital interversions are increasingly being used to manage mental health and stress. This narrative review shows recent evidence on the prevalence and risk factors of burnout in healthcare workers. We also wanted to show the effectiveness of digital and digitally assisted interventions, with focusing on resilience‑oriented and mindfulness‑based approaches. Randomized trials for apps such as PsyCovidApp, Headspace, Vitalk show small to moderate benefits for distress and selected burnout dimensions but they often struggle with low user engagement and can’t bypass the bigger issues: crushing workloads and lack of institutional support. Overall, digital tools appear to be useful, but they are not system‑level strategies to mitigate burnout.